An invoice will be sent to the Coordinating Center at the time of trial activation; payment is due within 30 days of issue. However, we provide a 90-day, money-back guarantee. If we receive an email message from the Coordinating Center within 90 days of the trial’s activation requesting its deactivation, a full refund will be given within 30 days.
Yes. Please see Doubled-Blinded Trials for more information.
Yes. For no additional cost, Randomize.net can create the randomization application to meet your specifications.
No. There is no cost for registering as a Coordinating Center or for a randomization application. Costs are incurred only when the application is activated.
Our website is hosted by a very secure and reliable server and the database is backed up continuously.
Our secure socket layer (SSL) software is the industry standard and among the best software available today for secure commerce transactions. It encrypts all information and subject data, so that it cannot be read as the information travels over the internet.
Yes. We currently provide three types of accrual reports: monthly by clinical site; by stratification variables; and, a treatment allocation list.
Have the Coordinating Center contact us at firstname.lastname@example.org and we will change subject ID number.
When randomizing a subject the clinical site must provide a subject ID number. No two subjects in the trial can have the same ID number. The best way to assign subject ID numbers is for each clinical site to maintain a registration log into which information about each subject is entered for clinical site use only. The information entered can vary depending on the trial. Typically, the information includes subject's name, date of randomization and the stratification variables. A pre-filled field in the registration log assigns the ID.
Yes. You can configure multiple email addresses for each clinical site, so that whenever a particular clinical site randomizes a subject, a confirmation is sent to each address. In addition, you can configure multiple email addresses to receive a confirmation for every randomization, regardless of clinical site.
See Randomization Algorithms for information on how randomization works.
Randomize.net, which is owned by Interrand Inc., was established in 2000 and developed under the supervision of Andrew Willan, PhD, Professor of Biostatistics, University of Toronto, and Professor Emeritus, Department of Clinical Epidemiology and Biostatistics, McMaster University.
We strive to provide all of our clients with top-quality service and support.